Issues surrounding the health economic evaluation of genomic technologies

Author： Buchanan James Wordsworth Sarah Schuh Anna

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.14, Iss.15, 2013-11, pp. : 1833-1847

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Decision Analytic Modelling in the Economic Evaluation of Health Technologies: A Consensus Statement

PharmacoEconomics, Vol. 17, Iss. 5, 2000-05 ,pp. : 443-444

Adis International

Access to resources Recommend Favorite

Transparency of Economic Evaluations of Health Technologies

By Rovira Joan

PharmacoEconomics, Vol. 26, Iss. 3, 2008-01 ,pp. : 181-183

Adis International

Access to resources Recommend Favorite

The changing role of economic evaluation in valuing medical technologies

By Rotter Jason S Foerster Douglas Bridges John FP

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 12, Iss. 6, 2012-12 ,pp. : 711-723

Informa Healthcare

Access to resources Recommend Favorite

Herbal Remedies: Issues in Licensing and Economic Evaluation

By Ashcroft D.M. Li Wan Po A.

PharmacoEconomics, Vol. 16, Iss. 4, 1999-10 ,pp. : 321-328

Adis International

Access to resources Recommend Favorite

New health technologies: better evaluation needed in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 281, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite